Driehaus Micro Cap Growth FundDMCRX
Type
Mutual fund
Peer group
US equity: small companies
Net assets
$457.7M
Expense ratio
1.37%
1-year return
+63.7%
3 years, a year
+24.1%
5 years, a year
+7.5%
Holdings
131
What it aims to do.
Driehaus Micro Cap Growth Fund seeks to maximize capital appreciation.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| PRAX Praxis Precision Medicines Inc | 2.60% |
| AAOI Applied Optoelectronics Inc | 2.21% |
| Northern Institutional Funds | 2.19% |
| PL Planet Labs Pbc | 1.84% |
| LASR Nlight Inc. | 1.70% |
| WULF Terawulf Inc | 1.65% |
| AMPX Amprius Technologies Inc. | 1.57% |
| SYRE Spyre Therapeutics Inc | 1.50% |
| XENE Xenon Pharmaceuticals Inc | 1.45% |
| Crinetics Pharmaceuticals Inc. | 1.39% |
More on DMCRX.
- DMCRX overview
- DMCRX holdings
- DMCRX risk
- DMCRX costs
- DMCRX money in and out
- DMCRX share classes
- Compare DMCRX with other funds
Returns after fees, from the fund's SEC filings up to Mar 2026. Past returns are not a promise. Not financial advice.